Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Desmopressin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A known ✓ | P37288 | 6/20 | 0.82 |
| ▸ | AVPR2 known ✓ | P30518 | 4/20 | 0.82 |
| ▸ | AVPR1B known ✓ | P47901 | 4/20 | 0.82 |
| ▸ | OXTR | P30559 | 9/20 | 0.82 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.82 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.69 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.69 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Desmopressin SCHEMBL204511 | 1.00 | OXTR (0.82) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Desmopressin SCHEMBL6021294 | 1.00 | OXTR (0.82) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Desmopressin SCHEMBL347838 | 0.99 | OXTR (0.81) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Desmopressin SCHEMBL28142694 | 0.99 | OXTR (0.81) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Desmopressin SCHEMBL4642385 | 0.99 | OXTR (0.81) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| SCHEMBL23382246 | 0.98 | OXTR (0.85) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Desmopressin SCHEMBL15933169 | 0.98 | OXTR (0.85) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Desmopressin SCHEMBL2687079 | 0.98 | OXTR (0.85) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Desmopressin SCHEMBL21131126 | 0.98 | OXTR (0.85) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Desmopressin SCHEMBL10053268 | 0.98 | OXTR (0.85) | OXTRAVPR1AAVPR2AVPR1BPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109153965-B | Method for improving algae growth | 特里同阿盖亚创新公司 | 2023-02-03 | — | — | CN | claimed |
| US-12637566-B2 | Bi-polymer thermoplastic | Dyksterhouse, Joel A. (US) | 2026-05-26 | — | — | US | disclosed |
| US-20260124826-A1 | HIGH ENERGY PROTECTIVE LAMINATES | GORE & ASS (US) | 2026-05-07 | — | — | US | disclosed |
| US-12617974-B2 | Partable laminate and method for parting long-term structural bonds | TESA SE (DE) | 2026-05-05 | — | — | US | disclosed |
| EP-4715019-A1 | ADHESIVE TAPE HAVING AN ELECTRICALLY DETACHABLE ADHESIVE SUBSTANCE LAYER, COMPOSITE, METHOD AND USE | TESA SE (DE) | 2026-03-25 | — | — | EP | disclosed |
| US-20260078283-A1 | ADHESIVE TAPE WITH AN ELECTRICALLY RELEASABLE ADHESIVE LAYER, ASSEMBLY, METHOD AND USE | TESA SE (DE) | 2026-03-19 | — | — | US | disclosed |
| EP-3757183-B1 | UV-CURING REACTIVE ADHESIVE | TESA SE (DE) | 2026-02-18 | — | — | EP | disclosed |
| EP-4688751-A1 | ANTIVIRAL HETEROCYCLIC COMPOUNDS | Enanta Pharmaceuticals, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| US-12540258-B2 | Light-curing reactive adhesive film | TESA SE (DE) | 2026-02-03 | — | — | US | disclosed |
| EP-4055218-B1 | FLAME RETARDANT COMPOSITE ARTICLES AND METHODS FOR REDUCING EXPOSURE TO FLAMES | GORE & ASS (US) | 2026-01-28 | — | — | EP | disclosed |
| EP-3969020-A1 | METHOD FOR ISOLATING MOLECULES CONTAINED IN THE ORGANOMINERAL LAYERS OF SHELLS OF BIVALVE MARINE MOLLUSKS | MBP (Mauritius) Ltd (MU) | 2022-03-23 | — | — | EP | disclosed |
| US-11274184-B2 | Bi-polymer thermoplastic | TRILLIUM MARKETING INC (US) | 2022-03-15 | — | — | US | disclosed |
| CN-114163938-A | Substrate-free hot melt adhesive film for soft package lithium battery and preparation method and application thereof | 烟台德邦科技股份有限公司 | 2022-03-11 | — | — | CN | disclosed |
| US-20220072760-A1 | METHOD AND FORMING TOOL FOR HOT-FORMING A FLAT THERMOPLASTIC LAMINATE | COVESTRO DEUTSCHLAND AG (DE) | 2022-03-10 | — | — | US | disclosed |
| EP-3963055-A1 | VECTORIZED ANTIBODIES (VAB) AND USES THEREOF | Voyager Therapeutics, Inc. (US) | 2022-03-09 | — | — | EP | disclosed |
| US-11267185-B2 | Method and device for producing a 3-D substrate coated with a laminate | LEONHARD KURZ STIFTUNG & CO. KG (DE) | 2022-03-08 | — | — | US | disclosed |
| US-20220049139-A9 | LATENT REACTIVE ADHESIVE FILM | TESA SE (DE) | 2022-02-17 | — | — | US | disclosed |
| US-20220048985-A1 | Anti-IL-6 Antibody | JANSSEN BIOTECH INC (US) | 2022-02-17 | — | — | US | disclosed |
| WO-2022023438-A1 | COMPOUNDS | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN (IE) | 2022-02-03 | — | — | WO | disclosed |
| US-11229652-B2 | Treatments for autoimmune disease | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN (IE) | 2022-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540258-B2 | Light-curing reactive adhesive film | ICAM1, MACF1, CDH1 | AVPR1A 3376/4885AVPR2 3713/4885AVPR1B 3119/4885 |
| US-12617974-B2 | Partable laminate and method for parting long-term structural bonds | MGMT, EPCAM, TMPO | AVPR1A 4603/4885AVPR2 4585/4885AVPR1B 4278/4885 |
| US-20260124826-A1 | HIGH ENERGY PROTECTIVE LAMINATES | HSF1, RNF31, CUTA | AVPR1A 4037/4885AVPR2 4136/4885AVPR1B 3916/4885 |
| US-12637566-B2 | Bi-polymer thermoplastic | LRBA, PCBP1, PHB1 | AVPR1A 4441/4885AVPR2 4043/4885AVPR1B 3942/4885 |
| US-20260078283-A1 | ADHESIVE TAPE WITH AN ELECTRICALLY RELEASABLE ADHESIVE LAYER, ASSEMBLY, METHOD AND USE | EPCAM, L1CAM, ICAM1 | AVPR1A 3198/4885AVPR2 3800/4885AVPR1B 3267/4885 |
| US-11229652-B2 | Treatments for autoimmune disease | QARS1, QTRT1, QTRT2 | AVPR1A 4573/4885AVPR2 4731/4885AVPR1B 4660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.